The Register on MSN
Quicksort inventor Tony Hoare reaches the base case at 92
Classicist, philosopher, wit, and one of the greatest British computer scientists of all time Obit Professor Charles Anthony Richard Hoare has died at the age of 92. Known to many computer science ...
His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial intelligence (AI). He is applying this to transferring as much of the load as ...
Did the writers become lazy? Did seeing a perfect AI suggestion make them suppress their own unique voices? The data says no. When Padmakumar and He ...
Discover the top 5 advanced AI technologies, from voice-first interfaces to proactive healthcare and cognitive offloading, ...
Something strange happened at University of California campuses this fall. For the first time since the dot-com crash, computer science enrollment dropped. System-wide, it fell 6% last year after ...
We offer a flexible option that provides both the foundations of computer science with space for a second major or minor, like mathematics, business management, data analytics or physics. In the field ...
A robot named Adam was the first of its kind to do science. Adam mimicked a biologist. After coming up with questions to ask about yeast, the machine tested those questions inside a robotic laboratory ...
An agent can produce a mathematically elegant, third-normal-form schema that is functionally irrelevant because it fails to capture the political or operational nuances of the organization. Deploying ...
Take our Readiness Self-Assessment to evaluate your skills and start your journey to success! Take the first step toward mastering data science with our tailored self-assessment tool. This resource ...
Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...
Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results